Old Web
English
Sign In
Acemap
>
Paper
>
CLINICAL ACTIVITY OF LONCASTUXIMAB TESIRINE PLUS IBRUTINIB IN NON-HODGKIN LYMPHOMA: UPDATED LOTIS 3 PHASE 1 RESULTS
CLINICAL ACTIVITY OF LONCASTUXIMAB TESIRINE PLUS IBRUTINIB IN NON-HODGKIN LYMPHOMA: UPDATED LOTIS 3 PHASE 1 RESULTS
2021
Julien Depaus
Nina Wagner-Johnston
P. L. Zinzani
Tycel J. Phillips
Joseph Maly
Silvia Ferrari
E. Bachy
Locke J. Bryan
Vincent Delwail
Murali Janakiram
S. de Guibert
Monica Tani
Vivian Dai
Karin Havenith
Joseph Boni
Xiaomin He
Annette Ervin-Haynes
C. Carlo-Stella
Keywords:
Ibrutinib
Phase (matter)
Internal medicine
hodgkin lymphoma
Medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]